Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 104

Sort by

Sort Order Select

Journal Articles

Favorable Outcomes of Newly Diagnosed Intravascular Large B-Cell Lymphoma Patients Treated with R-CHOP Combined with High-Dose Methotrexate Plus Intrathecal Chemotherapy: Results from a Multicenter Phase 2 Trial (PRIMEUR-IVL)

Blood (2019) 134 (Supplement_1): 350.

https://doi.org/10.1182/blood-2019-126798

Published: 2019

Journal Articles

Oral Ribavirin with or without the Addition of Immune Globulin for the Treatment of Lower Respiratory Tract Infections Due to Respiratory Syncytial Virus or Parainfluenza in Patients after Allogeneic Stem Cell Transplantation

Maria Stamouli, Ioannis Tsonis, MD, Konstantinos Gkirkas, Christina Economopoulou, Thomas Thomopoulos, MD, Anna Paisiou, MD, Nikolaos Siafakas, Spyridon Pournaras, Anastasia Antoniadou, Aggeliki Karagiannidi, Joseph Meletiadis, Dimitra Kavatha, George Vassilopoulos, MD PhD, Stavros Gigantes, MD, Ioannis Baltadakis, MD, Evgenios Goussetis, Dimitrios Karakasis, MD, Panagiotis Tsirigotis

Blood (2019) 134 (Supplement_1): 4498.

https://doi.org/10.1182/blood-2019-128362

Published: 2019

Journal Articles

Coexistence of a Huge Venous Thromboembolism and Bleeding Tendency in Cytokine Release Syndrome during CAR-T Therapy

Haiyan Liu, MD, Ye Yang, PhD, Hongming Huang, MD

Blood (2019) 134 (Supplement_1): 5590.

https://doi.org/10.1182/blood-2019-129389

Published: 2019

Journal Articles

Coagulopathy, Hypoxemia, and Mortality Outcomes in Newly Diagnosed Acute Myeloid Leukemia with Hyperleukocytosis Treated with Large Volume Leukapheresis

Bryan Hambley, MD, Eric Gehrie, Jonathan Webster, MD, Margaret M. Showel, MD, Lukasz P. Gondek, MD PhD, William Brian Dalton, MD PhD, Gabrielle T. Prince, MD, Douglas E Gladstone, MD, Ivana Gojo, MD, Gabriel Ghiaur, MD PhD, Keith W. Pratz, MD, B. Douglas Smith, MD, Amy E. DeZern, MD, Mark J. Levis, MD

Blood (2019) 134 (Supplement_1): 3841.

https://doi.org/10.1182/blood-2019-123229

Published: 2019

Journal Articles

Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Very Severe Veno-Occlusive Disease after Unmanipulated Haploidentical HSCT with Post-Transplant Cyclophosphamide

Ignacio Gómez-Centurión, MD, Nieves Dorado, MD, Rebeca Bailén, MD, Miguel Echenagusia, MD, Arturo Alvarez, MD, Gillen Oarbeascoa, MD, Cristina Muñoz, Javier Anguita, MD PhD, Jose L. Diez-Martin, MD PhD, Mi Kwon, MD

Blood (2019) 134 (Supplement_1): 1981.

https://doi.org/10.1182/blood-2019-125828

Published: 2019

Journal Articles

Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic Natural Killer Cells (NAM-NK) in Patients with Refractory Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma (MM)

Veronika Bachanova, MD PhD, David H. McKenna, MD, Xianghua Luo, PhD, Todd E. DeFor, MS, Fiona He, MD, Murali Janakiram, MD MS, Erica D. Warlick, MD, Rose Wangen, Zuzan Cayci, MD, Bartosz Grzywacz, MD, Guy Brachya, PhD, Tony Peled, MSc, Jeffrey S. Miller, MD

Blood (2019) 134 (Supplement_1): 777.

https://doi.org/10.1182/blood-2019-130476

Published: 2019

Journal Articles

A Novel Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD123 to Treat Relapsed Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Sanfang Tu, MD PhD, Lan Deng, MD PhD, Rui Huang, MD PhD, Xuan Zhou, MD, Jilong Yang, MD, Weijun Zhou, MD PhD, Meifang Li, MD PhD, Chunyan Yue, MD, Shaojie Wu, MD PhD, Zhenling Guo, Lung-Ji Chang, PhD, Yuhua Li, MD PhD

Blood (2018) 132 (Supplement 1): 4015.

https://doi.org/10.1182/blood-2018-99-118526

Published: 2018

Journal Articles

How KEAP1 Deletion in Single Cell Mitigates Sickle Cell Pathology

Nadine Keleku Lukwete, PhD, Mikiko Suzuki, PhD, Harit Panda, Akihito Otsuki, PhD, Fumiki Katsuoka, PhD, Ritsumi Saitou, MD, Daisuke Saigusa, PhD, Akira Uruno, MD PhD, Masayuki Yamamoto, MD PhD

Blood (2018) 132 (Supplement 1): 2353.

https://doi.org/10.1182/blood-2018-99-110502

Published: 2018

Journal Articles

Acquired Secondary Erythrocytosis in Long-Term Survivors of Allogeneic Hematopoietic Stem Cell Transplantation

Albina Kibirova, Sidra Najeeb, MD, Michael Craig, MD

Blood (2018) 132 (Supplement 1): 3422.

https://doi.org/10.1182/blood-2018-99-113592

Published: 2018

Journal Articles

Cytokine Release Syndrome after Peripheral Blood T-Cell Replete Haploidentical Transplantation Is Not Prevented By Dexamethasone and Limits Its Full-Outpatient Conduction

Perla R. Colunga Pedraza, MD, Andrés Gómez-De León, MD, Julia Esther Colunga Pedraza, MD, Emmanuel Bugarin Estrada, MD, Paola Santana-Hernandez, MD, Olga Cantu Rodriguez, MD, Cesar Homero Gutierrez Aguirre, MD, Luz del Carmen Tarín Arzaga, MD, José Miguel Yañez Reyes, MD, David Gomez-Almaguer, MD

Blood (2018) 132 (Supplement 1): 3355.

https://doi.org/10.1182/blood-2018-99-116996

Published: 2018

Journal Articles

Evaluation of Intravenous Diphenhydramine Use in Patients with Sickle Cell Vaso-Occlusive Crisis

Ifeyinwa Osunkwo, MD MPH, Shelby Merchant, PharmD, Rachel Crawford, PharmD, BCPS, Katherine Rector, PharmD, BCPS, Justin Arnall, PharmD, CPP, BCOP, James T Symanowski, PhD, Padmaja Veeramreddy, MD

Blood (2018) 132 (Supplement 1): 3575.

https://doi.org/10.1182/blood-2018-99-116848

Published: 2018

Journal Articles

Quality of Care Indicators in Patients with Sickle Cell Disease (SCD): Influenza Vaccination and Routine Eye Examination Are Associated with Outpatient Utilization but Not Acute Hospital Care, Whereas Comorbidity Indexes Are Strongly Associated with Both

Tom Adamkiewicz, MD FRCPC, MSc, Peter Baltrus, PhD, Chaohua Li, MPH, Kitty Carter-Wicker, MD, Anne Gaglioti, MD

Blood (2018) 132 (Supplement 1): 3574.

https://doi.org/10.1182/blood-2018-99-120132

Published: 2018

Journal Articles

Overview of Growth Development in Pediatric Patients Treated with Hydroxyurea (HU) in the Escort-HU Study

Lena Oevermann, MD, Mariane De Montalembert, MD PhD, Malika Benkerrou, MD, Valentine Brousse, MD, Corinne Pondarré, MD PhD, Marie Petras, MD, Marie Belloy, MD, Narcisse Elenga, MD PhD

Blood (2018) 132 (Supplement 1): 1079.

https://doi.org/10.1182/blood-2018-99-114441

Published: 2018

Journal Articles

Optimal Hemoglobin Level for Pediatric Sickle Cell Patients Who Undergo Adenotonsillectomy

Zhongbo Hu, MD PhD, Simone Megan Chang, MD, Ramzi Younis, MD, Ofelia A. Alvarez, MD

Blood (2018) 132 (Supplement 1): 4938.

https://doi.org/10.1182/blood-2018-99-119452

Published: 2018

Journal Articles

Hematological Changes from Baseline in Children with Sickle Cell Disease Admitted for Acute Chest Syndrome Compared to Acute Pain Crisis

Timothy Klouda, DO, Nataly Apollonsky, MD, Deepti Raybagkar, MD MS, Bruce Bernstein, PhD

Blood (2018) 132 (Supplement 1): 4909.

https://doi.org/10.1182/blood-2018-99-118977

Published: 2018

Journal Articles

Metabolic Profile & Body Composition in Egyptian Children with Transfusion-Dependent Egyptian B-Thalassemia

Mohsen Saleh Elalfy, MD, Fatma Soliman Elsayed Ebeid, MD MRCPCH, El Gendy Yasmin, MD, Elghamry Islam, MD, Kalifa Amna, MBBCh

Blood (2018) 132 (Supplement 1): 4903.

https://doi.org/10.1182/blood-2018-99-114260

Published: 2018

Journal Articles

Prevalence of High Body Mass Index in Children with Sickle Cell Disease and Its Correlation of Disease Severity

Rachael Hall, Kate Gardner, MA, MRCP, MBBS, David C Rees, MA, MBBS, FRCP, Subarna Chakravorty, MBBS, PhD FRCPath, MRCP

Blood (2017) 130 (Supplement 1): 3553.

https://doi.org/10.1182/blood.V130.Suppl_1.3553.3553

Published: 2017

Journal Articles

Congenital Methemoglobinemia Under Diagnosed Condition with Variiable Therapeurtic Options

Mohamed A. Yassin, MBBS,MSc,CABM,FACP,MSC, Dina Sameh Soliman, PhD

Blood (2017) 130 (Supplement 1): 4746.

https://doi.org/10.1182/blood.V130.Suppl_1.4746.4746

Published: 2017

Journal Articles

Increased Rate of Pulmonary Toxicity in Pediatric Patients with Relapsed Hodgkin Lymphoma Receiving Brentuximab Vedotin

Kelly E Faulk, MD, Jenna Sopfe, MD, Laura Pyle, PhD, Deborah R Liptzin, MD, Arthur K Liu, MD, Anna RK Franklin, MD, Carrye R Cost, MD

Blood (2017) 130 (Supplement 1): 4078.

https://doi.org/10.1182/blood.V130.Suppl_1.4078.4078

Published: 2017

Journal Articles

Comparative Outcomes of Immunochemotherapy with RCD (rituximab, cyclophosphamide, dexamethasone) and BCD (bortezomib, cyclophosphamide, dexamethasone) in Waldenstrom Macroglobulinaemia: NCT02971982

Jingjing Shang, Lingzhi Yan, Jin Zhou, Song Jin, Chengcheng Fu, Depei Wu, MD, Ying Yao

Blood (2017) 130 (Supplement 1): 5166.

https://doi.org/10.1182/blood.V130.Suppl_1.5166.5166

Published: 2017

NARROW

Favorable Outcomes of Newly Diagnosed Intravascular Large B-Cell Lymphoma Patients Treated with R-CHOP Combined with High-Dose Methotrexate Plus Intrathecal Chemotherapy: Results from a Multicenter Phase 2 Trial (PRIMEUR-IVL)

Oral Ribavirin with or without the Addition of Immune Globulin for the Treatment of Lower Respiratory Tract Infections Due to Respiratory Syncytial Virus or Parainfluenza in Patients after Allogeneic Stem Cell Transplantation

Coexistence of a Huge Venous Thromboembolism and Bleeding Tendency in Cytokine Release Syndrome during CAR-T Therapy

Coagulopathy, Hypoxemia, and Mortality Outcomes in Newly Diagnosed Acute Myeloid Leukemia with Hyperleukocytosis Treated with Large Volume Leukapheresis

Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Very Severe Veno-Occlusive Disease after Unmanipulated Haploidentical HSCT with Post-Transplant Cyclophosphamide

Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic Natural Killer Cells (NAM-NK) in Patients with Refractory Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma (MM)

A Novel Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD123 to Treat Relapsed Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

How KEAP1 Deletion in Single Cell Mitigates Sickle Cell Pathology

Acquired Secondary Erythrocytosis in Long-Term Survivors of Allogeneic Hematopoietic Stem Cell Transplantation

Cytokine Release Syndrome after Peripheral Blood T-Cell Replete Haploidentical Transplantation Is Not Prevented By Dexamethasone and Limits Its Full-Outpatient Conduction

Evaluation of Intravenous Diphenhydramine Use in Patients with Sickle Cell Vaso-Occlusive Crisis

Quality of Care Indicators in Patients with Sickle Cell Disease (SCD): Influenza Vaccination and Routine Eye Examination Are Associated with Outpatient Utilization but Not Acute Hospital Care, Whereas Comorbidity Indexes Are Strongly Associated with Both

Overview of Growth Development in Pediatric Patients Treated with Hydroxyurea (HU) in the Escort-HU Study

Optimal Hemoglobin Level for Pediatric Sickle Cell Patients Who Undergo Adenotonsillectomy

Hematological Changes from Baseline in Children with Sickle Cell Disease Admitted for Acute Chest Syndrome Compared to Acute Pain Crisis

Metabolic Profile & Body Composition in Egyptian Children with Transfusion-Dependent Egyptian B-Thalassemia

Prevalence of High Body Mass Index in Children with Sickle Cell Disease and Its Correlation of Disease Severity

Congenital Methemoglobinemia Under Diagnosed Condition with Variiable Therapeurtic Options

Increased Rate of Pulmonary Toxicity in Pediatric Patients with Relapsed Hodgkin Lymphoma Receiving Brentuximab Vedotin

Comparative Outcomes of Immunochemotherapy with RCD (rituximab, cyclophosphamide, dexamethasone) and BCD (bortezomib, cyclophosphamide, dexamethasone) in Waldenstrom Macroglobulinaemia: NCT02971982

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only